I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 26% ± 10% | |
| dendritic cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 26% ± 10% | |
| dendritic cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1272.33 | 226 / 226 | 100% | 30.59 | 406 / 406 |
| ovary | 100% | 1858.79 | 180 / 180 | 100% | 26.82 | 430 / 430 |
| pancreas | 100% | 1295.62 | 328 / 328 | 100% | 38.12 | 178 / 178 |
| prostate | 100% | 1795.42 | 245 / 245 | 100% | 45.97 | 502 / 502 |
| skin | 100% | 2012.29 | 1809 / 1809 | 100% | 50.88 | 472 / 472 |
| thymus | 100% | 1509.46 | 653 / 653 | 100% | 45.88 | 605 / 605 |
| uterus | 100% | 1569.15 | 170 / 170 | 100% | 51.30 | 459 / 459 |
| esophagus | 100% | 1464.83 | 1444 / 1445 | 100% | 28.44 | 183 / 183 |
| brain | 100% | 1376.80 | 2638 / 2642 | 100% | 49.94 | 705 / 705 |
| kidney | 100% | 1377.65 | 89 / 89 | 100% | 31.50 | 898 / 901 |
| breast | 100% | 1423.76 | 459 / 459 | 100% | 40.49 | 1114 / 1118 |
| intestine | 100% | 1597.58 | 966 / 966 | 99% | 47.17 | 524 / 527 |
| bladder | 100% | 1777.33 | 21 / 21 | 99% | 45.47 | 501 / 504 |
| stomach | 100% | 1197.76 | 358 / 359 | 100% | 40.27 | 285 / 286 |
| lung | 99% | 1211.94 | 574 / 578 | 100% | 35.94 | 1153 / 1155 |
| adrenal gland | 100% | 1599.24 | 258 / 258 | 99% | 27.00 | 227 / 230 |
| adipose | 100% | 1347.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 67.31 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 71.11 | 29 / 29 |
| muscle | 100% | 2228.12 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2013.15 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 49.77 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 28.33 | 1 / 1 |
| blood vessel | 100% | 1057.67 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 964.46 | 851 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 91% | 1160.17 | 844 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006308 | Biological process | DNA catabolic process |
| GO_0006281 | Biological process | DNA repair |
| GO_0006364 | Biological process | rRNA processing |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003690 | Molecular function | double-stranded DNA binding |
| GO_0004527 | Molecular function | exonuclease activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004519 | Molecular function | endonuclease activity |
| GO_0003697 | Molecular function | single-stranded DNA binding |
| GO_0008408 | Molecular function | 3'-5' exonuclease activity |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | REXO4 |
| Protein name | REX4 homolog, 3'-5' exonuclease RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2) |
| Synonyms | PMC2 XPMC2H |
| Description | |
| Accessions | Q9GZR2 A0A0C4DG31 ENST00000371942.8 [Q9GZR2-1] ENST00000445916.1 ENST00000454825.1 ENST00000628678.2 [Q9GZR2-2] ENST00000371935.6 [Q9GZR2-2] ENST00000630460.3 [Q9GZR2-1] A0A0C4DG22 |
